Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy
Author(s) -
Seiichiro Sugimoto,
Junichi Soh,
Ken Suzawa,
Kentaroh Miyoshi,
Shinji Otani,
Hiromasa Yamamoto,
Mikio Okazaki,
Masaomi Yamane,
Takahiro Oto,
Susumu Kanazawa,
Katsuyuki Kiura,
Shinichi Toyooka
Publication year - 2020
Publication title -
surgery today
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 63
eISSN - 1436-2813
pISSN - 0941-1291
DOI - 10.1007/s00595-020-01960-5
Subject(s) - medicine , pneumonectomy , lung cancer , chemoradiotherapy , radiation therapy , surgery , induction chemotherapy , chemotherapy , surgical oncology , survival rate , oncology
Some long-term survivors after surgery for locally advanced non-small cell lung cancer (NSCLC) treated with induction chemoradiotherapy (trimodality treatment) develop chronic pulmonary aspergillosis (CPA). The aim of our study was to assess the characteristics and outcomes of CPA that develops after trimodality treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom